SUPPORTING BIOTECH COMPANIES
in advancing clinical development of large molecule personalized medicine.
Increasing clinical development success
Dr. Anke Domdey
Who We Are
Consultancy company supporting Biotech companies in advancing clinical development of large molecule personalized medicine
Ando focus is on bioanalytical outsourcing and advice on clinical study plans as well as regulatory submissions/ queries in relation to bioanalytical outcome measures relevant for the development of large molecule personalized medicine.
Ando particpates in advancing the clinical development of new treatments of pediatric neuroblastoma by Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets based on a range of technologies licensed...
Ando supports PROvendis GmbH in advancing the commercialisation of a new treatment concept for viral infections
PROvendis GmbH is a patent licensing agency for the universities of North Rhine-Westphalia, Germany.